Prenyl Ammonium Salts - New Carriers for Gene Delivery: A B16-F10 Mouse Melanoma Model

被引:6
|
作者
Grecka, Emilia [1 ,2 ]
Statkiewicz, Malgorzata [3 ]
Gorska, Agnieszka [4 ]
Biernacka, Marzena [5 ]
Grygorowicz, Monika Anna [5 ]
Masnyk, Marek [6 ]
Chmielewski, Marek [6 ]
Gawarecka, Katarzyna [7 ]
Chojnacki, Tadeusz [7 ]
Swiezewska, Ewa [7 ]
Malecki, Maciej [4 ]
机构
[1] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Mol & Translat Oncol, Warsaw, Poland
[2] Natl Res Inst Mother & Child, Dept Pharmacol, Warsaw, Poland
[3] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Genet, Warsaw, Poland
[4] Med Univ Warsaw, Dept Appl Pharm & Bioengn, Warsaw, Poland
[5] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Immunol, Warsaw, Poland
[6] Inst Organ Chem PAS, Warsaw, Poland
[7] Inst Biochem & Biophys PAS, Warsaw, Poland
来源
PLOS ONE | 2016年 / 11卷 / 04期
关键词
LINKED CATIONIC LIPIDS; IN-VITRO; TISSUE INHIBITOR; DRUG CARRIERS; TRANSFECTION; COMPLEXES; LIPOPLEX; THERAPY; VECTORS; DOTAP;
D O I
10.1371/journal.pone.0153633
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose Prenyl ammonium iodides (Amino-Prenols, APs), semi-synthetic polyprenol derivatives were studied as prospective novel gene transfer agents. Methods AP-7, -8, -11 and -15 (aminoprenols composed of 7, 8, 11 or 15 isoprene units, respectively) were examined for their capacity to form complexes with pDNA, for cytotoxicity and ability to transfect genes to cells. Results All the carriers were able to complex DNA. The highest, comparable to commercial reagents, transfection efficiency was observed for AP-15. Simultaneously, AP-15 exhibited the lowest negative impact on cell viability and proliferation-considerably lower than that of commercial agents. AP-15/DOPE complexes were also efficient to introduce pDNA to cells, without much effect on cell viability. Transfection with AP-15/DOPE complexes influenced the expression of a very few among 44 tested genes involved in cellular lipid metabolism. Furthermore, complexes containing AP-15 and therapeutic plasmid, encoding the TIMP metallopeptidase inhibitor 2 (TIMP2), introduced the TIMP2 gene with high efficiency to B16-F10 melanoma cells but not to B16-F10 melanoma tumors in C57BL/6 mice, as confirmed by TIMP2 protein level determination. Conclusion Obtained results indicate that APs have a potential as non-viral vectors for cell transfection.
引用
收藏
页数:25
相关论文
共 50 条
  • [1] Microimaging characterization of a B16-F10 melanoma metastasis mouse model
    Winkelmann, Christopber T.
    Figueroa, Said Daibes
    Rold, Tammy L.
    Volkert, Wynn A.
    Hoffman, Timothy J.
    MOLECULAR IMAGING, 2006, 5 (02): : 105 - 114
  • [2] Proteomic analysis of tumor establishment and growth in the B16-F10 mouse melanoma model
    Culp, WD
    Neal, R
    Massey, R
    Egevad, L
    Pisa, P
    Garland, D
    JOURNAL OF PROTEOME RESEARCH, 2006, 5 (06) : 1332 - 1343
  • [3] Cancer gene therapy: The estimation of reporter genes delivery to B16-F10 melanoma cells
    Czajka, M.
    Zajkowska, A.
    Stachowiak, N.
    Malecki, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 67 - 67
  • [4] Dodoviscin A Inhibits Melanogenesis in Mouse B16-F10 Melanoma Cells
    Yan, Guirui
    Zhu, Jingjie
    Zhang, Laibin
    Xu, Zhijian
    Wang, Gaihong
    Zhu, Weiliang
    Hou, Aijun
    Wang, Heyao
    PLANTA MEDICA, 2013, 79 (11) : 933 - 938
  • [5] Therapeutic efficacy of the ZVex™ and GLAAS™ platforms in a B16-F10/hCAIX melanoma mouse model
    Campbell, David J.
    Reeves, Rebecca S.
    Flynn, Patrick A.
    Robbins, Scott H.
    Berglund, Peter
    ter Meulen, Jan H.
    CANCER RESEARCH, 2015, 75
  • [6] Effects of Thymol on B16-F10 Melanoma Cells
    Satooka, Hiroki
    Kubo, Isao
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2012, 60 (10) : 2746 - 2752
  • [7] Linking αMSH with PPARγ in B16-F10 melanoma
    Maresca, Vittoria
    Flori, Enrica
    Camera, Emanuela
    Bellei, Barbara
    Aspite, Nicaela
    Ludovici, Matteo
    Catricala, Caterina
    Cardinali, Giorgia
    Picardo, Mauro
    PIGMENT CELL & MELANOMA RESEARCH, 2013, 26 (01) : 113 - 127
  • [8] Comparison of four strategies for tumour vaccination in the B16-F10 melanoma model
    Souberbielle, BE
    Westby, M
    Ganz, S
    Kayaga, J
    Mendes, R
    Morrow, WJW
    Dalgleish, AG
    GENE THERAPY, 1998, 5 (11) : 1447 - 1454
  • [9] Comparison of four strategies for tumour vaccination in the B16-F10 melanoma model
    BE Souberbielle
    M Westby
    S Ganz
    J Kayaga
    R Mendes
    WJW Morrow
    AG Dalgleish
    Gene Therapy, 1998, 5 : 1447 - 1454
  • [10] STIMULATION OF MELANIN SYNTHESIS OF B16-F10 MOUSE MELANOMA-CELLS BY BUFALIN
    ZHANG, L
    YOSHIDA, T
    KUROIWA, Y
    LIFE SCIENCES, 1992, 51 (01) : 17 - 24